Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Pediatr Crit Care Med. 2020 Apr;21(4):e152–e159. doi: 10.1097/PCC.0000000000002185

Figure 2: Association between markers of immune paralysis and viral reactivation.

Figure 2:

2a. Box plots comparing median absolute lymphocyte count (ALC) with IQR at study days 0, 2-3, and 5-7 between patients with (black boxes) and without (gray boxes) reactivation viremia (including CMV, EBV, and HHV-6).

2b and 2c. Box plots comparing median ex vivo lipopolysaccharide (LPS)-stimulated whole blood tumor necrosis factor (TNF)-α production with IQR and median monocyte human leukocyte antigen (HLA)-DR expression with IQR, respectively, at study days 1, 3, and 8 between patients with (black boxes) and without (gray boxes) reactivation viremia (including CMV, EBV, and HHV-6).